Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-21-019458

EVP R&D, Chief Medical Officer gave up 368 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-06-07 Option exercise +1,250 1,250 D: show line 1 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-06-07 Shares withheld for taxes −368 $23.50 $8,648 882 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-06-07 Option exercise · Restricted Stock Unit Award −1,250 0 D: show line 3 in the form
Loading xslF345X03/form4.xml…